secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001217234-24-000062
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx Q1 revenue $72M (-7% YoY); raises FY2024 revenue guidance to $274-282M
-----------------------------------------------------------------------------

- Revenue $72.0M, down 7% YoY from $77.3M but up 10% sequentially from Q4 2023.
- Net loss $16.7M ($0.32 loss per share) improved from $23.7M loss ($0.44) a year ago.
- Testing Services revenue $53.8M, down 13% YoY but up 15% sequentially; patient results ~42,000, up 6% sequentially.
- Adjusted EBITDA loss $1.9M vs $6.4M loss in Q1 2023 and $10.3M loss in Q4 2023.
- Raises FY2024 revenue guidance to $274-282M; cash $216M with no debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723424000062/0001217234-24-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723424000062/cdna-20240509.htm
  HTML page:      https://secwatch.observer/filing/0001217234-24-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer